2000
DOI: 10.1016/s0167-5273(00)00317-x
|View full text |Cite
|
Sign up to set email alerts
|

Effects of progestin–estrogen replacement therapy on QT-dispersion in postmenopausal women

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
48
1
2

Year Published

2002
2002
2022
2022

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 54 publications
(52 citation statements)
references
References 18 publications
1
48
1
2
Order By: Relevance
“…Likewise, acute administration of supraphysiological doses of estrogen in healthy women produced no significant changes in QT and QTc intervals, whereas both QT and QTc prolonged significantly in women with syndrome X [30]. Haseroth et al [31] demonstrated that combined progestin -estrogen replacement therapy reduces the dispersion of ventricular repolarization in postmenopausal women compared to the control group and estrogen replacement therapy prolongs QT intervals, but does not affect QT dispersion. Larsen et al [18] demonstrated that estrogen, alone or in combination with progestins, had no significant effects on heart rate, QT interval, or corrected QT interval in post menopausal women without a structural heart disease.…”
Section: Discussionmentioning
confidence: 99%
“…Likewise, acute administration of supraphysiological doses of estrogen in healthy women produced no significant changes in QT and QTc intervals, whereas both QT and QTc prolonged significantly in women with syndrome X [30]. Haseroth et al [31] demonstrated that combined progestin -estrogen replacement therapy reduces the dispersion of ventricular repolarization in postmenopausal women compared to the control group and estrogen replacement therapy prolongs QT intervals, but does not affect QT dispersion. Larsen et al [18] demonstrated that estrogen, alone or in combination with progestins, had no significant effects on heart rate, QT interval, or corrected QT interval in post menopausal women without a structural heart disease.…”
Section: Discussionmentioning
confidence: 99%
“…Larsen, et al 14) have reported that no significant effect of HRT (estrogen or estrogen plus progesterone) was seen on the QT interval or QTc interval, and the estrogen effect in the dosages and forms given clinically should not increase a woman's risk for torsades de pointes. On the other hand, in a study conducted by Haseroth, et al 17) women receiving HRT for 3 months were separated into two groups-those given only estrogen and others given estrogen plus progesterone-and they were compared with the control group. Contrary to the study reported by Saba, et al in this study it was reported that QTd did not change, while QT duration was prolonged in the group administered only estrogen replacement.…”
Section: Discussionmentioning
confidence: 99%
“…On the other hand, a study in which women receiving HRT for 3 months were separated into two groups-those given only estrogen and others given estrogen plus progesterone-showed that QT dispersion (QTd) did not change, while QT duration was prolonged in the group with only estrogen replacement. In the same study it was stated that QTd decreased in the group receiving estrogen plus progesterone [15]. As a result, it was stated that HRT including estrogen plus progesterone homogenized the QT duration and therefore decreased the QTd.…”
Section: Discussionmentioning
confidence: 84%